Semorelin

Description

Growth Hormone Releasing Hormone (GHRH) Analog

Sermorelin is a synthetic 29-amino acid polypeptide representing the active truncated fragment of the endogenous Growth Hormone Releasing Hormone (GHRH 1-29). It is the shortest fully functional fragment of GHRH that retains the complete biological activity of the 44-amino acid parent molecule. In a research setting, it is utilized to stimulate the pituitary gland to secrete Growth Hormone (GH) in a natural, regulated manner.

The Science of Action

Sermorelin acts as a highly specific secretagogue, mimicking the signaling process that occurs in the hypothalamic-pituitary-somatotropic axis.

• Pituitary Somatotroph Activation: Sermorelin binds to the GHRH receptors on the somatotroph cells of the anterior pituitary. This binding triggers the adenylate cyclase pathway, increasing intracellular cAMP and stimulating the release of stored Growth Hormone.

• Preservation of the Feedback Loop: Unlike exogenous HGH, which can suppress natural production, Sermorelin works within the body’s natural feedback mechanisms. It is subject to inhibition by Somatostatin, meaning it is unlikely to cause the GH “spikes” associated with direct hormone administration, maintaining a more physiological secretion pattern.

• IGF-1 Modulation: By stimulating GH production, Sermorelin indirectly promotes the hepatic synthesis of Insulin-like Growth Factor 1 (IGF-1), the primary mediator of the peptide’s systemic effects on muscle, bone, and connective tissue.

Biochemical Specifications